This application note explores how VAX-ID supports yellow fever vaccination through accurate, easy-to-use intradermal delivery, highlighting its dose-sparing potential and key practical benefits.

This document includes:

• The benefits of dose-sparing vaccination to help address vaccine shortages
• The challenges of traditional intradermal injection techniques.
• How VAX-ID enables accurate and standardized vaccine delivery.
• Key advantages, including ease of use, low pain, time savings, and reduced vaccine use.

Read more here